Aveanna Healthcare Holdings Inc
NASDAQ:AVAH
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
2.16
5.945
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Aveanna Healthcare Holdings Inc
Cost of Revenue
Aveanna Healthcare Holdings Inc
Cost of Revenue Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cost of Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
A
|
Aveanna Healthcare Holdings Inc
NASDAQ:AVAH
|
Cost of Revenue
-$1.3B
|
CAGR 3-Years
-8%
|
CAGR 5-Years
-9%
|
CAGR 10-Years
N/A
|
|
|
DaVita Inc
NYSE:DVA
|
Cost of Revenue
-$8.5B
|
CAGR 3-Years
-2%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
0%
|
|
|
Quest Diagnostics Inc
NYSE:DGX
|
Cost of Revenue
-$6.4B
|
CAGR 3-Years
1%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
-4%
|
|
|
CVS Health Corp
NYSE:CVS
|
Cost of Revenue
-$316.5B
|
CAGR 3-Years
-10%
|
CAGR 5-Years
-10%
|
CAGR 10-Years
-11%
|
|
|
Cigna Corp
NYSE:CI
|
Cost of Revenue
-$206.5B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Laboratory Corporation of America Holdings
NYSE:LH
|
Cost of Revenue
-$9.2B
|
CAGR 3-Years
4%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
-9%
|
|
Aveanna Healthcare Holdings Inc
Glance View
Aveanna Healthcare Holdings, Inc. operates as a holding company. The company is headquartered in Atlanta, Georgia and currently employs 33,000 full-time employees. The company went IPO on 2021-04-29. The Company’s operating segments includes Private Duty Services (PDS), Medical Solutions (MS) and Home Health & Hospice (HHH). The firm provides a range of pediatric and adult healthcare services, including nursing, rehabilitation services, occupational nursing in schools, therapy services, day treatment centers for medically ill children and adults, home health and hospice services, as well as delivery of enteral nutrition and other products to patients. The company also provides case management services in order to assist the family and patient by coordinating the provision of services between the insurer or other payer, the physician, the hospital, and other healthcare providers. In addition, the Company provides respite healthcare services, which are temporary care provider services provided in relief of the patient’s normal caregiver. Its services are designed to provide an alternative to prolonged hospitalization.
See Also
What is Aveanna Healthcare Holdings Inc's Cost of Revenue?
Cost of Revenue
-1.3B
USD
Based on the financial report for Dec 30, 2023, Aveanna Healthcare Holdings Inc's Cost of Revenue amounts to -1.3B USD.
What is Aveanna Healthcare Holdings Inc's Cost of Revenue growth rate?
Cost of Revenue CAGR 5Y
-9%
Over the last year, the Cost of Revenue growth was -5%. The average annual Cost of Revenue growth rates for Aveanna Healthcare Holdings Inc have been -8% over the past three years , -9% over the past five years .
You don't have any saved screeners yet
